Relay Therapeutics Inc (RLAY) stock news · rev $15.4M
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
This RLAY news page leads with what Relay Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for RLAY yet. We will not pad this page with generic market recap.
Latest reported RLAY revenue for 2025-12-31 was $15.4M. Net income was -$276.5M. Revenue was up 53.4% from 2024-12-31 to 2025-12-31. RLAY currently screens at market cap $3.39B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RLAY stock page; for the tape open the quote page.
RLAY stock news FAQ
What are RLAY's latest revenue and net income?
Latest cached Relay Therapeutics Inc (RLAY) revenue for Dec 31, 2025 was $15.4M. Net income was -$276.5M. Statements: https://lician.com/financials/rlay
How did RLAY revenue change from the prior cached period?
Cached Relay Therapeutics Inc (RLAY) revenue was up 53.4% from $10.0M (Dec 31, 2024) to $15.4M (Dec 31, 2025). Statements: https://lician.com/financials/rlay
What is RLAY's market cap?
Relay Therapeutics Inc (RLAY) market cap is $3.39B on the latest cached fundamentals snapshot.
What kind of company is RLAY?
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Where is RLAY stock news listed?
Cached stock news for Relay Therapeutics Inc (RLAY) is listed at https://lician.com/news/rlay. Filings: https://lician.com/sec/rlay
Not investment advice.